A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans. - Wikidata - awgldk - TriplyDB

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.

http://www.wikidata.org/entity/Q39540314

about

Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease Powassan virus encephalitis, Minnesota, USA Dermacentor reticulatus: a vector on the rise.Analysis of the Langat Virus Genome in Persistent Infection of an Ixodes scapularis Cell Line Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques Protective efficacy of Zika vaccine in AG129 mouse model Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines.Current trends in West Nile virus vaccine development.Characterisation of divergent flavivirus NS3 and NS5 protein sequences detected in Rhipicephalus microplus ticks from Brazil Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne Diseases Flavivirus-induced antibody cross-reactivity.Kyasanur forest disease.Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.Vaccination and tick-borne encephalitis, central Europe.Single-dose vaccine against tick-borne encephalitis.Vaccines for viral hemorrhagic fevers--progress and shortcomings Tick-borne Encephalitis Vaccines.Vaccines and vaccination against tick-borne encephalitis.Louping ill virus: an endemic tick-borne disease of Great Britain.Review of tick-borne encephalitis and vaccines: clinical and economical aspects.Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis.Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations.Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection.

P2860

Q24273313-07C0EBD3-B40F-4C5D-B1DA-EC9D22F3B36C Q24629189-91034797-2F9A-4107-932A-D2483AB168DC Q26744141-A7B9AE5A-73D1-4C06-8BF1-ADAAF08B607D Q27468729-42EE1F5A-2FCF-4DDB-8B3A-6E7C533056E1 Q27980556-46EC7EAA-AFB9-4C40-9F2C-D1694373BB1E Q29378065-416CCAAF-B251-4D77-A3C6-28BAE43229E7 Q29994527-473979CC-B81F-4B6A-89E4-9DAE68944EC3 Q33812485-553E087C-2517-462B-AEF8-870FA9E3EFCF Q34325937-B73FE6A5-E6EA-4C8D-B7B3-63464ABF58EC Q34788758-73C2F265-00DE-4624-9C6C-2B6EEF27D216 Q35120221-90325BB1-EE3A-41FE-AB3B-1366325B8BFC Q35598662-75CA0A71-6AEA-4F1C-93E4-CCA0047240A4 Q35961340-D2352AB4-8B23-4EF8-A5A8-E18165481193 Q36442246-93EEAF14-CB1A-4578-9EA7-C3841A5DA893 Q36524044-0217113E-D6B0-49B6-ABC8-3E0C1CA90FE8 Q36570858-98C2DE97-1ECA-4CF5-B966-790BBEBB52F9 Q37088625-FB5EFB32-AEA6-492B-BEE1-31C05AEDC24C Q37096221-6BABA3FF-A2F1-41BB-93DD-697842C0D305 Q37127083-659E9541-56AA-4236-B0EA-AE0C0B8B4B9A Q38059753-F7489178-50F6-45D9-BBEC-6F14241459A1 Q38189522-1B0742C4-DB64-4228-9F02-841A4A5E4C59 Q38271711-E006DFF5-C1DF-4B88-86A6-43FC29D64993 Q38284708-585DA8C5-C32B-42E2-AA6F-3D8277E0D86A Q38649761-E18D9FEB-FC16-4DB3-BBE1-30D6FF98E2C3 Q40225317-F6AC9C15-A85C-40DC-B176-54F783B543B6 Q42559156-1FD6779F-01D8-4EBE-A7C6-D9FBBFE34CC3 Q47096633-BBD80BE4-10CC-4244-898D-0E9E8460329D

P2860

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.

http://www.wikidata.org/entity/Q39540314

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@en

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@nl

type

label

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@en

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@nl

prefLabel

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@en

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@nl

P1433

Q39540314-201705B1-63F8-4FF0-9E23-FFCD3FB04DE4

P1476

Q39540314-F685BD38-D852-4615-9E09-8F3F58E7B239

P2093

Q39540314-0FCD3115-AA44-4A0F-966C-95663D546560

Q39540314-17F4319E-59CE-420E-B461-5C59D5E78BCA

Q39540314-1AA29DFB-616A-4BA3-9C9E-73E7D48A1FB5

Q39540314-4249DB9C-6254-4207-8151-73987393B184

Q39540314-4DCECBBE-616F-451A-B2CA-D008645915CB

Q39540314-66A45167-0AEC-4D25-8FBA-0F922FC0D5E1

Q39540314-A79F16EC-810A-481C-B9F0-6E7DFB19165B

Q39540314-AA91B1FF-81B8-4C03-B4F7-AA8A66AEBAE5

Q39540314-DF9AC1A3-2618-415B-AFE3-71DE9F66D7EA

Q39540314-E1B0ACB5-373D-43ED-8713-CD6A29D80C11

P304

Q39540314-9D419284-A558-4E21-B9BE-CD77E9D0D319

P31

Q39540314-81144807-5994-41D8-8F27-EEF258365D23

P356

Q39540314-7D92D996-5591-4063-8BF9-846D0C0ED933

P407

Q39540314-81C2E20D-B577-43EB-AAB1-62A916FB398F

P433

Q39540314-341C6BE9-FA9B-4DE7-8612-EB0A266C126E

P478

Q39540314-25D7BDEA-4D9C-45C3-83F0-D64E228E45D0

P577

Q39540314-63AD8128-3385-48C5-92B6-A378967EEC98

P5875

Q39540314-1F672D2E-3690-4851-962F-DC5F3DC8ACF8

P698

Q39540314-89D03097-CE4A-4A6D-A812-7029D0E73228

P921

Q39540314-EB44A712-75C9-4516-9FCB-F22F99716DB0

P356

P1433

The Journal of Infectious Diseases

P1476

A tick-borne encephalitis viru ...... ralizing antibodies in humans.

@en

P2093

Alexandra Loew-Baselli

http://www.w3.org/2001/XMLSchema#string

Bernd Unger

http://www.w3.org/2001/XMLSchema#string

Eva-Maria Poellabauer

http://www.w3.org/2001/XMLSchema#string

Falko G Falkner

http://www.w3.org/2001/XMLSchema#string

Georg W Holzer

http://www.w3.org/2001/XMLSchema#string

Hartmut J Ehrlich

http://www.w3.org/2001/XMLSchema#string

Klaus K Orlinger

http://www.w3.org/2001/XMLSchema#string

P Noel Barrett

http://www.w3.org/2001/XMLSchema#string

Richard Fritz

http://www.w3.org/2001/XMLSchema#string

Thomas R Kreil

http://www.w3.org/2001/XMLSchema#string

P304

1556-1564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIR122

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51147013

http://www.w3.org/2001/XMLSchema#string

P698

21592984

http://www.w3.org/2001/XMLSchema#string

P921